HOME > TOP STORIES

TOP STORIES

REGULATORY Average Discrepancy Rate Remains at Approximately 8.4%: MHLW Flash Report

December 2, 2011
BUSINESS UK AstraZeneca CEO Brennan Says Investment in Japan, a “Very Important Market,” Will Continue

December 1, 2011
REGULATORY CSIMC Approves Outline of Plan to Promote Generic Drug Use

December 1, 2011
REGULATORY CSIMC Expert Member Yoshimura Says Conditions Must Improve to Promote Generics

November 30, 2011
BUSINESS AZ to Bolster Its Top Position in Breast Cancer Area

November 29, 2011
REGULATORY Record 101 Generics from 30 Companies Listed for Aricept

November 29, 2011
REGULATORY MHLW Says Sept Drug Price Settlement Rate Dips to 78.1%, Falling Below 2009 Level

November 28, 2011
REGULATORY CSIMC to Discuss Additional Price Cuts for Long-Listed Drugs

November 28, 2011
ORGANIZATION Economic Losses Due to Illness, Injury Total ¥3.3 Tril. Annually in Japan: ACCJ

November 28, 2011
REGULATORY DPJ's Subcommittee for PAL Amendment Begins Deliberations Nov. 28, to Compile Opinion by End-Jan

November 25, 2011
ORGANIZATION MSF Japan General Director Expresses Concern Over TPP Negotiations, Possible Generics Price Rise

November 25, 2011
REGULATORY Policy Screening Committee Proposes Major Cutbacks in Long-Listed Drug Prices, Additional Decreases Possible

November 24, 2011
BUSINESS 25 Leading Drug Makers Report Overall Decline in Sales, Profits in 1st Half

November 24, 2011
ACADEMIA JSMO Issues 33 Development Requests for Unapproved Drugs, Indications

November 22, 2011
BUSINESS Sanofi, Nichi-Iko to Copromote Latter's Generic Drugs

November 22, 2011
BUSINESS Sawai, Nichi-Iko Boost Inventory Ahead of Expected PAL Amendment

November 21, 2011
REGULATORY MHLW Study Group Postpones Decision on Relief System for Victims of Health Damages Due to Anticancer Drugs

November 21, 2011
REGULATORY After Delay, CSIMC Recommends Listing of Ilaris for Treatment of CAPS

November 21, 2011
ORGANIZATION 6 Indian Generics Companies Including Zydus Form Association, to Start Operations This Month

November 18, 2011
BUSINESS Teva to Merge Taiyo, Kowa-Teva, Establish “Teva Pharma Japan” in Mid-2012

November 18, 2011

ページ

Chuikyo Debate on FY2026 Drug Pricing Reform

Chuikyo OKs New CEA Handling, with Third-Party Verification Ahead

Japan’s cost-effectiveness assessment (CEA) panel has approved a revised handling policy for the CEA system for FY2026, with the health…

COMMENTARY

Shift Underway in Pharma Workforce as Sales Roles Shrink, Manufacturing Rises

By Hayate Horiguchi

Japan’s pharmaceutical industry is undergoing a structural shift in its workforce, with the role of sales reps shrinking while production…

COLUMN

The Patient North Star: How Gilead Japan Redefined Innovation

By Philip Carrigan

In the complex landscape of the Japanese pharmaceutical market, the “status quo” is often the safest harbor. But for leaders like Kennet Brysting, former president of Gilead Japan, the status quo is the most dangerous place to stay.Innovation in Japan…